Lidak Pharm. [LDAKA] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA]

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: luis a. garcia who wrote (215)	5/17/1997 11:54:00 PM
From: John Zwiener	of 1115

Luis, I misread the lidak press release. There were only 10 patients in the Kaposi's study, and 28 LESIONS studied (not 28 patients total). After, 3 months, all ten patients manifested a decrease in lesion size. If there was no selective info release here, this is very good. According to H Nimann on the Ligand thread, you would expect only 10 % of patients/lesion? to show spontaneous regression (no time frame was offered). I tend to think this is good additional evidence that lidakol works very well on herpes. By the way, other drugs I have become aware of for Kaposi's, that are in development, don't have near the results that we seem to be seeing here, and the folks on the other threads are excited about their results. That upcoming oral herpes study may just come through

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next